- Record: found
- Abstract: not found
- Article: not found
Cancer and Leukemia Group B (Alliance), SWOG, and ECOG (2014) CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC)
AP Venook, D Niedzwiecki, H-J Lenz, F INNOCENTI, MR Mahoney, BH O'Neil, JE SHAW, BN Polite, HS Hochster, JN Atkins, RM Goldberg, RJ MAYER, RL Schilsky, MM Bertagnolli, CD Blanke
2017
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.